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Fluoro-2-deoxy-D-glucose–positron emission tomography
(FDG-PET) has been used widely in detecting, staging, and
monitoring the therapy in various types of malignancy.
However, FDG is not specific for cancer. Some benign
conditions such as infection or inflammation have been
reported to cause FDG uptake [1]. Differentiating between
benign and malignant lesions is challenging, even though
semiquantitative analysis, such as the standard uptake
value (SUV), is regularly used as a supplemental tool for
image interpretation [2]. Therefore, it is important to
acknowledge the conditions that may mimic malignancy so
as to reduce misinterpretation. Here we present a patient
who underwent an FDG-PET scan because of suspected
malignancy. The FDG-avid lesion in the abdomen was later
proved by tissue biopsy to be secondary to tuberculosis
(TB) infection. To the best of our knowledge, this is the first
case report of the application of FDG-PET in jejunal TB.
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A 32-year-old male had suffered from persistent dull epigastric pain, constipation, postprandial vomiting,
and body-weight loss for 2 months. An abdominal computed tomography (CT) scan showed thickening of
the proximal jejunal wall. He was also referred to our center for an fluoro-2-deoxy-D-glucose–positron
emission tomography (FDG-PET) scan because his tumor marker CA19-9 was above 800 ng/mL and
malignancy was suspected. The PET scan showed an FDG-avid lesion over the upper left abdomen.
Endoscopy of the small intestine revealed focal thickening of the mucosal fold and skip ulcer lesions in the
jejunum. Culture from the biopsy tissue proved the diagnosis of Mycobacterium tuberculosis infection. No
evidence of pulmonary tuberculosis was detected during further evaluation.
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CASE PRESENTATION
A 32-year-old man who had been well and without any
systemic disease began to suffer from epigastric pain, which
lasted for 2 months. The initial epigastric pain was cramping
in character and accompanied by cold sweating. Thereafter,
the epigastric pain was dull and persistent, occasionally
exacerbated for a few minutes and then changing to
cramping pain. The pain became worse after food intake
without radiation to other regions. In addition, he noted
epigastric fullness, postprandial vomiting 3–4 hours after
intake, constipation, and body weight loss of about 8 kg
over the past 2 months. He visited a hospital, where it was
noted that his serum CA19-9 level was elevated to above
800 ng/mL. PET scan was recommended for further
evaluation. He visited our hospital for a second opinion.
Because malignancy was suspected, an FDG-PET scan was
done. An area of increased FDG uptake in the upper left
abdomen with an SUV of 5.4 was demonstrated on the
1-hour imaging. On the delayed 3-hour imaging, the
FDG-avid lesion in the upper left abdomen remained in
the same place with a higher SUV of 6.2 (Figure 1). An
abdominal computed tomography (CT) scan showed
thickening of the proximal jejunal wall (Figure 2).
© 2006 Elsevier. All rights reserved.
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Figure 2. (A) The transverse section of fluoro-2-deoxy-D-glucose–
positron emission tomography (FDG-PET) F-18 scan shows a lesion in
the left upper abdomen (arrows). (B) An abdominal CT scan shows
nonspecific focal thickening of the mucosal fold in the jejunum (arrows).
(C) An FDG-PET/CT image fusion shows that the FDG-avid lesion at
the left upper abdomen is consistent with the jejunal lesion shown on
the CT image.
Figure 1. Fluoro-2-deoxy-D-glucose–positron emission tomography (FDG-PET) scan was performed 1 and 3 hours after injection of 370 MBq of
FDG F-18. (A) The coronary section of the 1-hour image. There is an area of increased FDG uptake at the upper left abdomen with an SUV of
5.4 (arrows). (B) The coronary section of the delayed 3-hour imaging. The FDG-avid lesion in the upper left abdomen remains in the same place with
a higher SUV of 6.2 (arrows), which was later confirmed by tissue culture from endoscopic biopsy to be a tuberculosis infection at the jejunum.
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The CA19-9 level was elevated from 1,460 to 2,006 ng/mL.
Endoscopy of the small intestine showed focal thickening
of the mucosal fold and skip ulcer lesions in the jejunum.
Culture from the biopsy tissue confirmed the presence of
Mycobacterium tuberculosis infection. No evidence of
pulmonary TB was detected during further evaluation.
A full 6-month course of Rifinah (rifampicin + isoniazid)
600 mg/day, ethambutol 800 mg/day, and pyramide
500 mg three times per day was prescribed. The serum level
of CA19-9 decreased gradually after the patient received
anti-TB therapy.
DISCUSSION
Although pulmonary manifestations predominate in most
cases of TB, gastrointestinal (GI) involvement may be present
as part of a multiorgan disease process or, less commonly,
as primary GI TB [3]. Intestinal TB occurs relatively
infrequently in Western countries, but immigrants and
immunosuppressed patients such as those with acquired
immunodeficiency syndrome continue to be at particular
risk for this disease. Other groups at risk include those with
alcohol dependency, intravenous drug users, those who
take long-term steroids, and the elderly (older than
65 yrs). The major site of intestinal TB involvement is in the
ileocecal region, such as with Crohn's disease. The affinity
of M. tuberculosis for this site may be due to the acid
environment produced by the stomach, the rapid transit of
gastric contents through the duodenum, and the relatively
greater number of lymphatic vessels and tissue in the
ileocecal segment. The case we present is a rare condition of
primary jejunal TB.
The diagnosis of intestinal TB is difficult, especially
in those without evidence of pulmonary TB or
immunosuppression. The symptoms and signs are
nonspecific and related to the site involved. The most
common symptom is abdominal pain, which accounts for
80–90% of cases with GI TB. Other symptoms include
diarrhea, fever, anorexia, weight loss, constipation, and
hemorrhage [4]. Taking the routine laboratory tests into
consideration, about 50–80% of cases show mild anemia
and increased erythrocyte sedimentation rate. The tuberculin
skin test may be positive in most patients. However, it does
not differentiate active disease from previous sensitization
by contact or vaccination [5]. The best radiologic imaging
modality is CT scan, which can assess intraluminal and
extraluminal disease and its extent [6]. When the
inflammation is mild, CT demonstrates only slight
symmetrical mural thickening and a few small regional
nodes. When the pathologic process is severe and advanced,
the bowel wall is thickened, and the inflammatory mass
may have a heterogeneous appearance. Large regional nodes
with hypoattenuating centers may be present, indicating
caseous necrosis [7]. Definitive diagnosis is based primarily
on histologic findings (Ziehl-Neelsen staining for acid-fast
bacilli) and culture, although the reported sensitivity of
each test is quite variable. Combining the results from
histology and culture of biopsy material can establish the
diagnosis in as many as 80% of patients [8].
In addition to uptake in malignancy, FDG has been
shown to accumulate in both acute inflammatory tissues [9]
and chronic inflammatory processes [10]. Even in tumors,
as much as 29% of the FDG uptake could derive from
nontumor tissues [11]. Activated inflammatory cells such
as neutrophils, lymphocytes, and macrophages have
markedly increased glycolysis that accounts for FDG
uptake in inflammatory tissue [12]. FDG uptake in
pulmonary TB has been widely discussed, whereas there
are few reports about FDG accumulation in extrapulmonary
TB. We believe this is the first report of FDG uptake in
jejunal TB.
This 32-year-old male had no history of pulmonary TB
or any conditions that may be associated with
immunodeficiency such as diabetes mellitus, alcoholism,
renal insufficiency, long-term steroid use, or advanced age.
He underwent an FDG-PET scan for tumor survey because
of clinical manifestations, including a significantly elevated
CA19-9 level and body-weight loss, which led to the
suspicion of malignancy. The FDG-avid lesion with high
SUV may support the suspicion as well. Fortunately, the
endoscopic biopsy and tissue culture proved the benign
course of the disease and prevented extensive surgery or
other unnecessary management. This result supports the
approach that endoscopy with biopsy is the most useful
nonoperative diagnostic test for intestinal TB [13,14].
CA19-9, a carbohydrate antigen related to Lewis blood
group antigen, has been shown to exist in the form of
glycolipids or glycoproteins on the cell surface. The
differentiation and oncogenic transformation of cells lead
to a change in glycosylation on the cell surface, thus affecting
the expression of tumor-associated carbohydrate antigens
such as CA19-9 [15]. The serum CA19-9 level is elevated
primarily in patients with carcinoma of the GI tract. As a
tumor marker, CA19-9 is helpful in post-therapeutic
monitoring to determine the efficacy of therapy or the
development of recurrence when used serially. In addition
to the malignancies, noncancerous conditions that may
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elevate CA19-9 level include acute pancreatitis,
inflammatory disease of the bowel, cirrhosis, cholecystitis,
biliary obstruction, gastric ulcer, chronic hepatitis C,
smoking, and benign pulmonary disease [16,17]. TB is one
of the benign pulmonary diseases that may correlate with
elevated CA19-9 levels [18,19]. Similar to that in malignancy,
the serum CA19-9 level correlates well with the disease
activity [18,19]. In the current case, the significantly elevated
serum CA19-9 level returned to normal after effective
treatment for TB.
The GI tract, especially the intestine, is a site well known
for physiologic accumulation of FDG. Among the sites with
physiologic FDG uptake in the intestine, 78.5% are presented
in the colon [20]. The intestinal FDG uptake may pose a
practical problem in the evaluation of PET images. In cases
of intraluminal secretion, the typical uptake pattern is focal
and may change with time [20]. Therefore, a delayed image
may be useful to distinguish the physiologic intestinal
uptake from the pathologic uptake. In our case, FDG
accumulation was noted at the left lower abdomen on the
1-hour image. The FDG accumulation disappeared on the
delayed image and was considered to be physiologic bowel
activity (Figure 1). In contrast, the FDG-avid lesion in the
upper left abdomen remained there and showed an even
higher SUV on the delayed 3-hour image. Pathologic uptake
was more likely in this region. However, it is still difficult to
prove that the FDG-avid lesion is exactly the lesion shown
on CT scan. A PET/CT scan or image fusion may be helpful
in solving this problem. In this case, the FDG-PET/CT
image fusion was performed and showed that the PET-avid
lesion was consistent with the lesion seen on the CT image
(Figure 2). Furthermore, the CT image showed that the
lesion of thickened mucosa was located in the proximal
jejunum. The tissue cultured for diagnosis was also obtained
at the same region by endoscopy. Therefore, we considered
that the FDG-avid lesion shown in the PET scan was the
same lesion of TB infection.
CONCLUSIONS
PET is widely applied in clinical practice, particularly for
oncologic application with FDG. The intestine is a
well-known site of physiologic accumulation of FDG in
PET. In addition to malignancy or physiologic uptake,
abdominal TB should be considered in patients with
abnormal FDG accumulation in the intestine with various
abdominal complaints, because the symptoms and signs of
primary intestinal TB are vague and nonspecific.
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